New Research Released on Precision Therapeutics Inc. (AIPT-NASDAQ)

Posted by Karen Goldfarb

July 9, 2018 at 12:34 PM

An Executive Informational Overview (EIO) is now available on medical technology company, Precision Therapeutics Inc. (AIPT-NASDAQ). The EIO is a 70-page report detailing Precision Therapeutics' business, product development, strategic relationships, market opportunities, competition, financials, risks, and more. It is available for download below.

VIEW REPORT

Read More

Topics: precision therapeutics, aipt, personalized medicine, precision medicine, artificial intelligence (AI), medical fluid waste collection, precision oncology, genomic, bioinformatics, STREAMWAY System, Skyline Medical, D-CHIP™, Helomics® Corporation, TumorGenesis, GLG Pharma

Receive Our Research Notifications

About This Blog

We provide investor-based research and corporate communications services to companies worldwide. Visit our About Us page to learn more.

Posts by Topic